Form 8-K - Current report:
SEC Accession No. 0001558370-25-003587
Filing Date
2025-03-25
Accepted
2025-03-25 08:40:16
Documents
51
Period of Report
2025-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20250325x8k.htm   iXBRL 8-K 43851
2 EX-99.1 apre-20250325xex99d1.htm EX-99.1 150894
3 EX-99.2 apre-20250325xex99d2.htm EX-99.2 55156
4 GRAPHIC apre-20250325xex99d1002.jpg GRAPHIC 8841
5 GRAPHIC apre-20250325xex99d2g001.jpg GRAPHIC 98627
6 GRAPHIC apre-20250325xex99d2g002.jpg GRAPHIC 302070
7 GRAPHIC apre-20250325xex99d2g003.jpg GRAPHIC 172084
8 GRAPHIC apre-20250325xex99d2g004.jpg GRAPHIC 119650
9 GRAPHIC apre-20250325xex99d2g005.jpg GRAPHIC 133754
10 GRAPHIC apre-20250325xex99d2g006.jpg GRAPHIC 170125
11 GRAPHIC apre-20250325xex99d2g007.jpg GRAPHIC 56471
12 GRAPHIC apre-20250325xex99d2g008.jpg GRAPHIC 189355
13 GRAPHIC apre-20250325xex99d2g009.jpg GRAPHIC 82176
14 GRAPHIC apre-20250325xex99d2g010.jpg GRAPHIC 158218
15 GRAPHIC apre-20250325xex99d2g011.jpg GRAPHIC 108084
16 GRAPHIC apre-20250325xex99d2g012.jpg GRAPHIC 57402
17 GRAPHIC apre-20250325xex99d2g013.jpg GRAPHIC 74019
18 GRAPHIC apre-20250325xex99d2g014.jpg GRAPHIC 144562
19 GRAPHIC apre-20250325xex99d2g015.jpg GRAPHIC 213728
20 GRAPHIC apre-20250325xex99d2g016.jpg GRAPHIC 153546
21 GRAPHIC apre-20250325xex99d2g017.jpg GRAPHIC 132929
22 GRAPHIC apre-20250325xex99d2g018.jpg GRAPHIC 131673
23 GRAPHIC apre-20250325xex99d2g019.jpg GRAPHIC 136176
24 GRAPHIC apre-20250325xex99d2g020.jpg GRAPHIC 53828
25 GRAPHIC apre-20250325xex99d2g021.jpg GRAPHIC 167319
26 GRAPHIC apre-20250325xex99d2g022.jpg GRAPHIC 117745
27 GRAPHIC apre-20250325xex99d2g023.jpg GRAPHIC 152520
28 GRAPHIC apre-20250325xex99d2g024.jpg GRAPHIC 124278
29 GRAPHIC apre-20250325xex99d2g025.jpg GRAPHIC 106556
30 GRAPHIC apre-20250325xex99d2g026.jpg GRAPHIC 58346
31 GRAPHIC apre-20250325xex99d2g027.jpg GRAPHIC 130701
32 GRAPHIC apre-20250325xex99d2g028.jpg GRAPHIC 193515
33 GRAPHIC apre-20250325xex99d2g029.jpg GRAPHIC 169759
34 GRAPHIC apre-20250325xex99d2g030.jpg GRAPHIC 119951
35 GRAPHIC apre-20250325xex99d2g031.jpg GRAPHIC 78354
36 GRAPHIC apre-20250325xex99d2g032.jpg GRAPHIC 162808
37 GRAPHIC apre-20250325xex99d2g033.jpg GRAPHIC 173157
38 GRAPHIC apre-20250325xex99d2g034.jpg GRAPHIC 146311
  Complete submission text file 0001558370-25-003587.txt   6675525

Data Files

Seq Description Document Type Size
39 EX-101.SCH apre-20250325.xsd EX-101.SCH 4091
40 EX-101.DEF apre-20250325_def.xml EX-101.DEF 2846
41 EX-101.LAB apre-20250325_lab.xml EX-101.LAB 16595
42 EX-101.PRE apre-20250325_pre.xml EX-101.PRE 10905
53 EXTRACTED XBRL INSTANCE DOCUMENT apre-20250325x8k_htm.xml XML 4677
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 25766002
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)